IP Verse

Sofar competitive analysis

Loading summary...

Latest oppositions filed by Sofar

Explore patent oppositions filed by Sofar against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3143985
Use Of Probiotic Microorganisms To Reduce Skin IrritationL'OREALMay 14, 2020

Latest patents of Sofar opposed by its competitors

Explore Sofar's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3439637
Jul 30, 2025Process For Mesalazine Solid Formulations1
EP2461802
Aug 3, 2022Controlled-Release Granular Compositions Containing Mesalazine And Process For The Manufacture Thereof1

Latest publications and patents of Sofar New

Explore the latest publications and patents granted to Sofar, showcasing their recent innovations and technological advancements.

Last updated on: Oct 17, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Sofar

EP3439637
Jul 30, 2025Process For Mesalazine Solid FormulationsPatent Maintained As Amended
EP2461802
Aug 3, 2022Controlled-Release Granular Compositions Containing Mesalazine And Process For The Manufacture ThereofPatent Maintained As Amended

Latest PTAB cases involving Sofar

Discover the latest PTAB cases involving Sofar, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sofar with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SOFAR12 - -
TILLOTTS PHARMA31 - -